![\"Shenzhen](\"https:\/\/www.csoftintl.com\/wp-content\/uploads\/2016\/07\/shenzhen100_web.jpg\")
<\/a><\/p>\n\u201cChina has gotten to the point where genuine innovation is occurring in its economy which is much needed. It appears that Shenzhen is at the epicenter of the innovation revolution in China,\u201d said Bill Powell, the Asia Editor & Chief International Correspondent of Newsweek Magazine.<\/p>\n
Looking specifically at four industries (based on China\u2019s five-year plan for growth and development), CSOFT International<\/a>, a globalization service provider with offices in Asia and throughout the Americas and Europe, created an index of companies \u2013 labeled as a Shenzhen 100 Riser\u2122, or a Shenzhen 100 Transformer\u2122 \u2013 whose innovative ideas have the best potential for global expansion.<\/p>\n Amongst the Shenzhen 100 Transformer\u2122 list is Chinese conglomerate Tencent, the country\u2019s largest internet and mobile-gaming company and a true testament to the success that is emerging from the city. Tencent recently acquired 84 percent of mobile-game developer, Supercell, which Venturebeat noted, \u201c\u2026isn\u2019t just about capitalizing on China. Gaming is global, and the company is growing far beyond its home country now.\u201d<\/p>\n As the global business and entrepreneurial center of China and a top 4 contributor to China\u2019s national GDP, Shenzhen is undeniably a thriving environment for global expansion. CSOFT wanted to measure and further understand the large concentration of Chinese companies driving innovation throughout the city. They embarked on an in-depth research mission measuring Shenzhen companies not by asset or revenue, but by each company\u2019s global maturity index (GMI\u2122).<\/p>\n “Innovation doesn\u2019t mean it\u2019s already a great company, innovation means it’s a company that is doing something that no one else has done. Through the Shenzhen 100\u2122, CSOFT has a chance to identify innovation and assist those unique companies as they move towards becoming great,” said Michael Kuan, CEO of Kuan Capital, a multibillion dollar hedge fund creating investment opportunities across technology, health, and sustainability industries.<\/p>\n On June 22nd, CSOFT hosted the China Globalization Forum to discuss and showcase Chinese companies\u2019 innovations which coincided with the launch of the first ever China GMI\u2122. Keynote speakers included Marisa Drew of Credit Suisse, Wang Huiyao the Founder and President of Center for China Globalization, and Wang Shi, the Founder & Chairman of China Vanke to lead the Forum\u2019s discussions on the current business climate in China \u2013 specifically the climate in Shenzhen.<\/p>\n \u201cShenzhen is constantly producing products which add value to the market. We want to combine the use of proven metrics from global consulting companies and our own expertise as a globalization service provider to help companies and investors alike understand the potential that Chinese companies have,\u201d said Shunee Yee, President and CEO of CSOFT.<\/p>\n Following a lively media Q&A session, the event\u2019s speaking portion came to a close and attendees poured through the reception area for a hands-on product exhibition from some of the city\u2019s top companies. Among the displays were Breo Technology\u2019s luxury portable massage machines and a sneak preview of Marisfrolg\u2019s designer fashion line. Guests also got to experience Royole\u2019s \u201cvirtual mobile movie theater\u201d and Super D\u2019s glasses-free 3D hardware; just a small sample of the cutting-edge technology that is ready to make a big impact around the world.<\/p>\n For more information on the Shenzhen 100\u2122, please visit http:\/\/www.csoftintl.com\/sz100\/<\/a> to register and receive a copy of the Executive Summary. To learn more about the companies on our list, please contact the people below.<\/p>\n\n CSOFT Health Sciences, leaders in clinical trial localization, provides AI\/ML-enabled medical translation services for all phases of the drug and medical device product lifecycle, from development to post-launch. We also specialize in DCT solutions, linguistic validation, and CTD\/eCTD submissions with the FDA, EMA, and NMPA. Our operations are certified in ISO 17100:2015, ISO 9001:2015, and ISO 13485:2016, ensuring our customized solutions meet the rigorous regulatory requirements of MMA, NDA, CTA, and Medical Device Application submissions. www.csoftintl.com<\/u><\/a><\/p>\n \n <\/div>\n\r\n About CSOFT Health Sciences<\/h3>\n